|
[1]
|
Gao GF. From “A”IV to “Z”IKV: attacks from emerging and re-emerging pathogens. Cell 2018;172(6):1157 − 9. http://dx.doi.org/10.1016/j.cell.2018.02.025CrossRef
|
|
[2]
|
WHO. Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. [2019-12-26]. https://www.who.int/en/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year.https://www.who.int/en/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year |
|
[3]
|
Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006;12(1):9 − 14. http://dx.doi.org/10.3201/eid1201.051254CrossRef
|
|
[4]
|
Miller M, Hagan E. Integrated biological-behavioural surveillance in pandemic-threat warning systems. Bull World Health Organ 2017;95(1):62 − 8. http://dx.doi.org/10.2471/BLT.16.175984CrossRef
|
|
[5]
|
Wang DY, Shu YL. History and reflection of pandemic influenza. Sci Sin Vitae 2018;48(12):1247 − 51. http://dx.doi.org/10.1360/N052018-00205 (In Chinese). CrossRef
|
|
[6]
|
Kissling E, Pozo F, Buda S, Vilcu AM, Gherasim A, Brytting M, et al. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort. Euro Surveill 2019;24(48):1 − 12. http://dx.doi.org/10.2807/1560-7917.ES.2019.24.48.1900604CrossRef
|
|
[7]
|
Zhang L, van der Hoek W, Krafft T, Pilot E, van Asten L, Lin G, et al. Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China. Hum Vaccin Immunother 2019. http://dx.doi.org/10.1080/21645515.2019.1677438CrossRef
|
|
[8]
|
Bellino S, Bella A, Puzelli S, Di Martino A, Facchini M, Punzo O, et al. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy. Expert Rev Vaccin, 2019;18(11):1201-9. http://dx.doi.org/10.1080/14760584.2019.1688151. |